Prof Christophe Pomel is an expert in Oncology at Centre Jean Perrin (France). As of August 2026, ScienceLeadR ranks Christophe Pomel in the top 1% of experts worldwide for Adnexal Diseases, Gonadal Disorders and Endocrine Gland Neoplasms. Christophe Pomel has authored 218 publications, the most recent in 2026, and is an investigator in 7 clinical trials. SLR score: 551 (community average: 125). How the SLR is computed.

LeadR Profile

Prof Christophe Pomel Centre Jean Perrin France
551 ScienceLeadR Reputation 551
Network Map

Oncology

Subspecialties: Gynecology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 1996 - 2026

Source: PubMed

Centre Jean Perrin

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 218

Citations

Citations: 6 074 1st author: 24 Last author: 25 Unique author: 0


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Study Protocol for Assessment of the Feasibility of an Intraoperative Localization Technique Using Augmented Reality in Breast-Conserving Surgery for Non-Palpable Cancer Lesions: A Feasibility Study.
PMID 42661930 — feasibility studies, breast neoplasms, augmented reality, neoplasms, breast, wounds and injuries
Health Sci Rep20260
Efficacy of secondary cytoreductive surgery for relapsed ovarian low-grade serous carcinoma: a multicenter analysis from French TMRG network.
PMID 42411723 — cytoreduction surgical procedures, ovary, neoplasms, ovarian neoplasms
J Gynecol Oncol20260
Advanced high-grade serous ovarian cancer treated with intensive cytoreductive surgery and chemotherapy: prognostic impact of lymph node involvement: analysis of the French national ESME-Unicancer database.
PMID 42013623 — cytoreduction surgical procedures, lymph nodes, ovary, neoplasms, drug therapy, lymph, ovarian neoplasms, therapeutics, dissection, prognosis, chemotherapy
Eur J Surg Oncol20260
Surgical approach and maintenance therapy in advanced low-grade serous ovarian cancer: Insights from the French ESME database.
PMID 41411701 — progression-free survival, ovary, genital neoplasms, female, neoplasms, bevacizumab, maintenance, ovarian neoplasms, therapeutics
Int J Gynecol Cancer20250
Diagnostic laparoscopy and cytoreduction surgery in ovarian cancer FIGO III-IV: The impact on survival of one-stage versus two-stage sequence.
PMID 40896861 — genital neoplasms, female, neoplasms, laparoscopy, ovarian neoplasms
Gynecol Oncol20250

Clinical Studies 7

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 2

By phase:

N/A 5
Phase 2 1
Phase 3 1

By status:

Active not recruiting 2
Completed 2
Suspended 1
Unknown 1
Withdrawn 1

By type:

Interventional 6
Observational 1

By Monocentric/Multicentric:

monocentric 1
multicentric2to4 1
multicentric5to9 0
multicentricup10 5

Main Topics

LeadR Networks

Main global connection map